NCT01138514

Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels

A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo Israel Pharmaceuticals, Ltd., Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to a Comparator Clindamycin / Benzoyl Peroxide Topical Gel, and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 1,555 (actual)
• Sponsor: Padagis LLC · Industry
• Sex: All
• Age: 12 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the efficacy and safety profiles of Perrigo Israel Pharmaceuticals, Ltd. Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel and Benzaclin® Topical Gel (Clindamycin- Benzoyl Peroxide Gel).

Conditions

• Acne Vulgaris

Interventions

Type	Name	Description
DRUG	Clindamycin 1% / Benzoyl Peroxide 5% (Perrigo)	Applied to the entire face twice daily for 10 weeks
DRUG	Clindamycin 1% / Benzoyl Peroxide 5% (Benzaclin)	Applied to the entire face twice daily for 10 weeks
DRUG	Placebo	Placebo

Timeline

• Start date: 2009-10-01
• Primary completion: 2010-10-01
• Completion: 2010-10-01
• First posted: 2010-06-07
• Last updated: 2021-10-13
• Results posted: 2016-03-29